drugset / Trial / NCT02446158

Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients

NCT02446158

Phase 4 Completed 89 enrolled E-DA Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Chlorhexidine is used in central line dressing changes and is effective in reducing line infections. It is unclear if daily chlorhexidine care at the exit site in peritoneal dialysis (PD) patients can reduce the risk of Staphylococcus aureus (SA) colonization or exit site infection.

Timeline

Start
2010-05
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 4 % Topical

Indications

No indication recorded.